All AbMole products are for research use only, cannot be used for human consumption.
CP-724714 is a potent and selective orally active HER-2 tyrosine kinase inhibitor under development for the treatment of advanced HER2-overexpressing cancers. CP-724714 has no appreciable activity toward EGFR (IC50 = 6400 nM) and is furthermore selective with respect to insulin receptor, IGF1R, PDGFRβ, VEGFR2, ABL, SRC and CDK.
| Cell Experiment | |
|---|---|
| Cell lines | ZR-75-30, HCC-1419, MDA-MB-175, BT-474, SKBR3, MDA-MB-361, UACC-812, T-47D, MDA-MB-453, MDA-MB-468, CAMA-1, MDA-MB-157, MCF-7, MDA-MB-435, ZR-75-1, BT-20, and MDA-MB-231cells line |
| Preparation method | Cell proliferation assays. Cells were seeded in duplicate at 5,000 to 10,000 per well in 24-well plates. The day after plating, CP-724,714 was added by titrating over six or more dilutions from 10 μmol/L down. Control wells without drug were seeded as well. Cells were grown for 6 to 7 days, at which time surviving cells were counted. After trypsinization, cells were placed in isotone solution and counted immediately using a Coulter Z2 particle counter (Beckman Coulter, Inc.). Growth inhibition was calculated [(1- experimental value / control value) × 100] for each concentration. Dose-response curves were repeated at least twice and averaged. IC50 values were calculated using Calcusyn Software (Biosoft). |
| Concentrations | 0~10 μ M |
| Incubation time | 6-7 days |
| Animal Experiment | |
|---|---|
| Animal models | Athymic female mice bearing human tumor cells (BT-474 and MDA-MB-453) xenograft models |
| Formulation | formulated in 0.5% methylcellulose |
| Dosages | 30 and 100mg/kg bid for 8-40 days |
| Administration | p.o. |
| Molecular Weight | 469.53 |
| Formula | C27H27N5O3 |
| CAS Number | 537705-08-1 |
| Solubility (25°C) | DMSO |
| Storage |
Powder -20°C 3 years ; 4°C 2 years In solvent -80°C 6 months ; -20°C 1 month |
| Related EGFR/HER2 Products |
|---|
| Sevabertinib
Sevabertinib is an epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor with antitumor activity. |
| BPIQ-I
BPIQ-I (PD 159121) is a potent and ATP-competitive EGFR tyrosine kinase inhibitor.. |
| HKI-357
HKI-357 is an irreversible dual inhibitor of EGFR and ERBB2 with IC50s of 34 nM and 33 nM, respectively. |
| SJF-1528
SJF-1528 is a potent EGFR PROTAC degrader with DC50 values of 39.2 nM and 736.2 nM for wild-type EGFR in OVCAR8 cells and Exon 20 Ins mutated EGFR in HeLa cells. |
| CH7233163
CH7233163 is a noncovalent ATP-competitive inhibitor for EGFR-Del19/T790M/C797S. |
All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
